Zydus Wellness · NSE: ZYDUSWELL · BSE: 531335

Q4 FY23 results · Jan–Mar 2023

Zydus Wellness reported revenue from operations of ₹712.98 crore (up 11.4% from Q4 FY22) and net profit of ₹145.33 crore (up 9.0% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations712.98639.78+11.4%415.58+71.6%
Other income0.721.96−63.3%0.84−14.3%
Total income713.70641.74+11.2%416.42+71.4%
Profit before tax126.33131.40−3.9%19.31+554.2%
Net profit for the period145.33133.30+9.0%19.56+643.0%
Attributable to shareholders of the company145.61136.19+6.9%19.49+647.1%
EPS, basic (₹)22.8420.95+9.0%3.07+643.9%
Net margin (%)20.420.84.7
Standalone · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations58.7460.43−2.8%63.72−7.8%
Other income3.583.55+0.8%3.34+7.2%
Total income62.3263.98−2.6%67.06−7.1%
Profit before tax10.515.93+77.2%14.40−27.0%
Net profit for the period28.6613.41+113.7%15.03+90.7%
EPS, basic (₹)4.502.11+113.3%2.36+90.7%
Net margin (%)48.822.223.6
Consolidated
Filed with BSE
17 May 2023, 17:40 IST
Board meeting
17 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
17 May 2023, 17:40 IST
Board meeting
17 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Unaudited
Source
XBRL filing on BSE